Dr David Gilligan

David Gilligan is a Consultant Oncologist at Cambridge University Hospitals & Papworth Hospitals, Cambridge, UK and an Associate Lecturer at the University of Cambridge. He trained in Oncology at the Christie Hospital, Manchester, Royal Marsden Hospital, and University College Hospitals, London. His main clinical interests are in Thoracic Oncology and Upper Gastrointestinal Oncology. He is an enthusiastic participator in clinical trials and has a keen interest in patient engagement and patient information. He has been a member of the NCRI Lung Cancer Studies Group. He currently sits on NHS England Lung Cancer Clinical Expert Group (CEG). He is Chair of Lung Cancer Group, Anglia Cancer Network, Senior Medical Editor to Macmillan Cancer Information and Specialist Advisor to CancerHelp UK, a Trustee and Chair of Grants Committee of the Roy Castle Lung Cancer Foundation, the major patient facing UK wide lung cancer charity. Since May 2017 he has been a member of BTOG Steering Committee.

Radiation therapy (incl. SABR and IMRT/VMAT) and systemic therapies (incl. chemotherapy, targeted therapy and immunotherapy) for the following Thoracic Oncology Lung cancer Mesothelioma Thymic Tumours Oesophago-gastric cancer Cancer Unknown Primary / Malignancy Unknown Origin